147 related articles for article (PubMed ID: 16961440)
1. The effects of prescription drug copayments on statin adherence.
Gibson TB; Mark TL; McGuigan KA; Axelsen K; Wang S
Am J Manag Care; 2006 Sep; 12(9):509-17. PubMed ID: 16961440
[TBL] [Abstract][Full Text] [Related]
2. Impact of statin copayments on adherence and medical care utilization and expenditures.
Gibson TB; Mark TL; Axelsen K; Baser O; Rublee DA; McGuigan KA
Am J Manag Care; 2006 Dec; 12 Spec no.():SP11-9. PubMed ID: 17173486
[TBL] [Abstract][Full Text] [Related]
3. Lowering copayments: impact of simvastatin patent expiration on patient adherence.
Sedjo RL; Cox ER
Am J Manag Care; 2008 Dec; 14(12):813-8. PubMed ID: 19067498
[TBL] [Abstract][Full Text] [Related]
4. Impact of decreasing copayments on medication adherence within a disease management environment.
Chernew ME; Shah MR; Wegh A; Rosenberg SN; Juster IA; Rosen AB; Sokol MC; Yu-Isenberg K; Fendrick AM
Health Aff (Millwood); 2008; 27(1):103-12. PubMed ID: 18180484
[TBL] [Abstract][Full Text] [Related]
5. Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort study.
Ye X; Gross CR; Schommer J; Cline R; St Peter WL
Clin Ther; 2007 Dec; 29(12):2748-57. PubMed ID: 18201593
[TBL] [Abstract][Full Text] [Related]
6. Drug copayment and adherence in chronic heart failure: effect on cost and outcomes.
Cole JA; Norman H; Weatherby LB; Walker AM
Pharmacotherapy; 2006 Aug; 26(8):1157-64. PubMed ID: 16863491
[TBL] [Abstract][Full Text] [Related]
7. Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment.
Schneeweiss S; Patrick AR; Maclure M; Dormuth CR; Glynn RJ
Circulation; 2007 Apr; 115(16):2128-35. PubMed ID: 17420348
[TBL] [Abstract][Full Text] [Related]
8. Cost-sharing effects on adherence and persistence for second-generation antipsychotics in commercially insured patients.
Gibson TB; Jing Y; Kim E; Bagalman E; Wang S; Whitehead R; Tran QV; Doshi JA
Manag Care; 2010 Aug; 19(8):40-7. PubMed ID: 20822071
[TBL] [Abstract][Full Text] [Related]
9. The impact of reducing cardiovascular medication copayments on health spending and resource utilization.
Choudhry NK; Fischer MA; Avorn JL; Lee JL; Schneeweiss S; Solomon DH; Berman C; Jan S; Lii J; Mahoney JJ; Shrank WH
J Am Coll Cardiol; 2012 Oct; 60(18):1817-24. PubMed ID: 23040581
[TBL] [Abstract][Full Text] [Related]
10. Copayment level and compliance with antihypertensive medication: analysis and policy implications for managed care.
Taira DA; Wong KS; Frech-Tamas F; Chung RS
Am J Manag Care; 2006 Nov; 12(11):678-83. PubMed ID: 17090224
[TBL] [Abstract][Full Text] [Related]
11. Effect of tiered prescription copayments on the use of preferred brand medications.
Rector TS; Finch MD; Danzon PM; Pauly MV; Manda BS
Med Care; 2003 Mar; 41(3):398-406. PubMed ID: 12618643
[TBL] [Abstract][Full Text] [Related]
12. Increasing copayments and adherence to diabetes, hypertension, and hyperlipidemic medications.
Maciejewski ML; Bryson CL; Perkins M; Blough DK; Cunningham FE; Fortney JC; Krein SL; Stroupe KT; Sharp ND; Liu CF
Am J Manag Care; 2010 Jan; 16(1):e20-34. PubMed ID: 20059288
[TBL] [Abstract][Full Text] [Related]
13. Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among Texas Medicaid recipients.
Cheong C; Barner JC; Lawson KA; Johnsrud MT
Clin Ther; 2008 Oct; 30(10):1893-907. PubMed ID: 19014846
[TBL] [Abstract][Full Text] [Related]
14. The effect of switching on compliance and persistence: the case of statin treatment.
Thiebaud P; Patel BV; Nichol MB; Berenbeim DM
Am J Manag Care; 2005 Nov; 11(11):670-4. PubMed ID: 16268750
[TBL] [Abstract][Full Text] [Related]
15. Effect of copayments on drug use in the presence of annual payment limits.
Kephart G; Skedgel C; Sketris I; Grootendorst P; Hoar J
Am J Manag Care; 2007 Jun; 13(6 Pt 2):328-34. PubMed ID: 17567233
[TBL] [Abstract][Full Text] [Related]
16. Effect of increased copayments on pharmacy use in the Department of Veterans Affairs.
Stroupe KT; Smith BM; Lee TA; Tarlov E; Durazo-Arvizu R; Huo Z; Barnett T; Cao L; Burk M; Cunningham F; Hynes DM; Weiss KB
Med Care; 2007 Nov; 45(11):1090-7. PubMed ID: 18049350
[TBL] [Abstract][Full Text] [Related]
17. Effect of statin adherence on cerebrovascular disease in primary prevention.
Perreault S; Ellia L; Dragomir A; Côté R; Blais L; Bérard A; Lalonde L
Am J Med; 2009 Jul; 122(7):647-55. PubMed ID: 19559167
[TBL] [Abstract][Full Text] [Related]
18. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
19. Copayment level, treatment persistence, and healthcare utilization in hypertension patients treated with single-pill combination therapy.
Yang W; Kahler KH; Fellers T; Orloff J; Chang J; Bensimon AG; Wu EQ; Fan CP; Yu AP
J Med Econ; 2011; 14(3):267-78. PubMed ID: 21446895
[TBL] [Abstract][Full Text] [Related]
20. Associations between prescription copayment levels and β-blocker medication adherence in commercially insured heart failure patients 50 years and older.
Patterson ME; Blalock SJ; Smith AJ; Murray MD
Clin Ther; 2011 May; 33(5):608-16. PubMed ID: 21665045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
